Anti-Insulin-like Growth Factor Binding Protein-4 produced in goat Antibody
如果您對(duì)該產(chǎn)品感興趣的話,可以
產(chǎn)品名稱: Anti-Insulin-like Growth Factor Binding Protein-4 produced in goat Antibody
產(chǎn)品型號(hào): Y062095
產(chǎn)品展商: 其他品牌
產(chǎn)品文檔: 無相關(guān)文檔
簡(jiǎn)單介紹
Anti-Insulin-like Growth Factor Binding Protein-4 produced in goat Antibody
Anti-Insulin-like Growth Factor Binding Protein-4 produced in goat Antibody
的詳細(xì)介紹
| Overview |
Print Version
|
| Product Name |
Anti-Insulin-like Growth Factor Binding Protein-4 produced in goat Antibody |
| Description |
Anti-Insulin-like Growth Factor Binding Protein-4 antibody produced in goat affinity isolated antibody, lyophilized powder |
| Subtype |
polyclonal |
| Application |
WB,ELISA,other |
| Raised In |
goat |
| Specificity |
By immunoblotting and ELISA, the antibody show no cross-reactivity with recombinant human IGFBP-2, recombinant human IGFBP-3, recombinant human IGFBP-1, recombinant human IGFBP-5, and recombinant human IGFBP-6. |
| Immunogen |
purified, NSO-derived, recombinant human insulin-like growth factor binding protein 4. |
| Guarantee |
abm guarantees that all our Anti-Insulin-like Growth Factor Binding Protein-4 produced in goat Antibody will perform as described on this product webpage, if this is not the case we will provide you with a one-time replacement at no extra cost. Documentation and explanation of experiment conducted will be required when submitting a claim for replacement. |
| Properties |
|
| Formulation |
Liquid |
| Quantity |
100 μg |
| Storage |
This product is stable for several weeks at 4°C as an undiluted liquid. Dilute only prior to immediate use. For extended storage, aliquot contents and freeze at -20°C or below. Avoid cycles of freezing and thawing. Expiration date is one (1) year from date of receipt. |
| Storage Buffer |
PBS, pH 7.4 with 0.05% sodium azide. |
| Concentration |
1μg/ul |
| Purity |
affinity isolated antibody |
| Species Reactivity |
human |
| Specific References |
|
Y062095 has not yet been referenced specifically in any publications.
|
